Invention Grant
- Patent Title: Pharmaceutical compounds
-
Application No.: US15931782Application Date: 2020-05-14
-
Publication No.: US11377443B2Publication Date: 2022-07-05
- Inventor: Neil Anthony Pegg , Stuart Thomas Onions , David Michel Adrien Taddei , Jonathan Shannon , Silvia Paoletta , Richard James Brown , Don Smyth , Gareth Harbottle
- Applicant: CELLCENTRIC LTD
- Applicant Address: GB Cambridge
- Assignee: CELLCENTRIC LTD
- Current Assignee: CELLCENTRIC LTD
- Current Assignee Address: GB Cambridge
- Agency: MH2 Technology Law Group, LLP
- Priority: GB1617630 20161018
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D413/14 ; C07D471/04 ; A61K45/06
Abstract:
A compound which is an arylimidazolyl isoxazole of formula (I): (Formula (I)) or a pharmaceutically acceptable salt thereof. The compound has activity in modulating the activity of p300 and/or CBP and is used to treat cancer, particularly prostate cancer.
Information query
